Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882


News SummaryMost relevantAll newsSector news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411;

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
09:11a GLAXOSMITHKLINE : GSK to support training of frontline health workers across Gha..
04:51a GLAXOSMITHKLINE : Glaxo Submits Japan Application For Mepolizumab In Eosinophili..
02:27a GLAXOSMITHKLINE : *berenberg cuts glaxosmithkline price target to 1570 pence - '..
05/21DJLaw Firm Advising Teva Dismisses Mylan Objections
05/21DJLaw Firm Advising Teva on Bid Dismisses Mylan's Objections to Its Involvement
05/21 GLAXOSMITHKLINE : Adaptimmune Announces New Additions to Senior Clinical Managem..
05/21 GLAXOSMITHKLINE : *citigroup cuts glaxosmithkline price target to 1550 pence - '..
05/21 GLAXOSMITHKLINE : *jefferies cuts glaxosmithkline price target to 1450 pence - '..
05/20 GlaxoSmithKline could be £95bn target for Pfizer, say bank analysts
05/19 GLAXOSMITHKLINE : GSK presents data at ATS on the role of blood eosinophil level..
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Copyright © 2015 Surperformance. All rights reserved.